S

Second Sight Medical Products Inc
NASDAQ:EYES

Watchlist Manager
Second Sight Medical Products Inc
NASDAQ:EYES
Watchlist
Price: 4.14 USD -5.05% Market Closed
Updated: May 27, 2024

Operating Margin
Second Sight Medical Products Inc

0%
Current
-301.8%
Average
4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-8.9m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Second Sight Medical Products Inc
NASDAQ:EYES
163.2m USD N/A
US
Abbott Laboratories
NYSE:ABT
180.8B USD
16%
US
Intuitive Surgical Inc
NASDAQ:ISRG
143.6B USD
25%
US
Stryker Corp
NYSE:SYK
127.8B USD
21%
US
Boston Scientific Corp
NYSE:BSX
111.2B USD
17%
IE
Medtronic PLC
NYSE:MDT
109.4B USD
20%
US
Becton Dickinson and Co
NYSE:BDX
66.4B USD
11%
DE
Siemens Healthineers AG
XETRA:SHL
60B EUR
12%
US
Edwards Lifesciences Corp
NYSE:EW
53B USD
29%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
364.9B CNY
35%
US
Dexcom Inc
NASDAQ:DXCM
50.5B USD
17%
S
Second Sight Medical Products Inc
NASDAQ:EYES
Country US
Market Cap 163.2m USD
Operating Margin N/A
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 180.8B USD
Operating Margin
16%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 143.6B USD
Operating Margin
25%
Stryker Corp
NYSE:SYK
Country US
Market Cap 127.8B USD
Operating Margin
21%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 111.2B USD
Operating Margin
17%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 109.4B USD
Operating Margin
20%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 66.4B USD
Operating Margin
11%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 60B EUR
Operating Margin
12%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 53B USD
Operating Margin
29%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 364.9B CNY
Operating Margin
35%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 50.5B USD
Operating Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Second Sight Medical Products Inc.

Full Profitability Report

See Also

Summary
EYES intrinsic value, competitors valuation, and company profile.
DCF Valuation
EYES stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EYES stock valuation using valuation multiples.
Wall Street Estimates
EYES price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EYES stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-8.9m
/
Revenue
0
What is the Operating Margin of Second Sight Medical Products Inc?

Based on Second Sight Medical Products Inc's most recent financial statements, the company has Operating Margin of 0%.

ALPHA SPREAD
Join more than 141,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.